Aïda Falgàs
-
- Nanoparticle-Based Drug Delivery 4
-
- Immunotherapy and Immune Responses 6
- Toxin Mechanisms and Immunotoxins 3
- Biotechnology top 10%
-
- Chemokine receptors and signaling 4
- CAR-T cell therapy research 3
-
- Acute Myeloid Leukemia Research 3
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Glycosylation and Glycoproteins Research 3
- Co-authors
- Ramón ManguesIsolda CasanovaEsther VázquezUgutz UnzuetaAntonio VillaverdeNaroa SernaVíctor PallarèsLaura Sánchez‐García
- Cited by
- BiomaterialsImmunologyBiotechnology
- Partner nations
- SpainArgentinaUnited Kingdom
In The Last Decade
Aïda Falgàs
18 papers receiving 382 citations
Peers
Comparison fields: 5 of 59
- Biomaterials 87
- Immunology 132
- Biotechnology 53
- Oncology 103
- Hematology 39
Countries citing papers authored by Aïda Falgàs
This map shows the geographic impact of Aïda Falgàs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aïda Falgàs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aïda Falgàs more than expected).
Fields of papers citing papers by Aïda Falgàs
This network shows the impact of papers produced by Aïda Falgàs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aïda Falgàs. The network helps show where Aïda Falgàs may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aïda Falgàs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 11 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 10 | |
| 7 | 2021 | 20 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 23 | |
| 10 | 2021 | 16 | |
| 11 | 2020 | 26 | |
| 12 | 2020 | 51 | |
| 13 | 2020 | 31 | |
| 14 | 2019 | 47 | |
| 15 | 2019 | 46 | |
| 16 | 2018 | 9 | |
| 17 | 2018 | 45 | |
| 18 | 2018 | 7 |
About Aïda Falgàs
Aïda Falgàs is a scholar working on Immunology, Hematology and Oncology, having authored 18 papers that have together received 385 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Nanoparticle-Based Drug Delivery (4 papers), Chemokine receptors and signaling (4 papers), Glycosylation and Glycoproteins Research (3 papers), Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (3 papers) and Toxin Mechanisms and Immunotoxins (3 papers). The work is most often cited by research in Biomaterials (87 citations), Immunology (132 citations) and Biotechnology (53 citations). Aïda Falgàs has collaborated with scholars based in Spain, Argentina and United Kingdom. Frequent co-authors include Ramón Mangues, Isolda Casanova, Esther Vázquez, Ugutz Unzueta, Antonio Villaverde, Naroa Serna, Víctor Pallarès, Laura Sánchez‐García, Alberto Gallardo and Jorge Sierra. Their work appears in journals such as Pharmaceutics, Cancers, Journal of Controlled Release, Biomaterials and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.